Safety and Efficacy Study of a BTK Inhibitor in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Clinical trial NCT01325701 · COMPLETED
Trial details
- NCT number
- NCT01325701
- Sponsor
- Pharmacyclics LLC.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2014-10-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.